Distinct fibroblast functions associated with fibrotic and immune-mediated inflammatory diseases and their implications for therapeutic development
F1000Research · 10.01.2024 · 13 · 54
DOI: 10.12688/f1000research.143472.1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift F1000Research, online erschienen am 10.01.2024. Verfasst von Alexander M S Barron und 2 weiteren Autor:innen. Beteiligte Einrichtung: Inflammation & Immunology Research Unit, Pfizer, Inc., Cambridge, Massachusetts, 02139, USA. Hauptthemen laut MEDLINE: Fibroblasts, Inflammation, Fibrosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 399 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.
Abstract (Originalsprache)
Fibroblasts are ubiquitous cells that can adopt many functional states. As tissue-resident sentinels, they respond to acute damage signals and shape the earliest events in fibrotic and immune-mediated inflammatory diseases. Upon sensing an insult, fibroblasts produce chemokines and growth factors to organize and support the response. Depending on the size and composition of the resulting infiltrate, these activated fibroblasts may also begin to contract or relax thus changing local stiffness within the tissue. These early events likely contribute to the divergent clinical manifestations of fibrotic and immune-mediated inflammatory diseases. Further, distinct changes to the cellular composition and signaling dialogue in these diseases drive progressive fibroblasts specialization. In fibrotic diseases, fibroblasts support the survival, activation and differentiation of myeloid cells, granulocytes and innate lymphocytes, and produce most of the pathogenic extracellular matrix proteins. Whereas, in immune-mediated inflammatory diseases, sequential accumulation of dendritic cells, T cells and B cells programs fibroblasts to support local, destructive adaptive immune responses. Fibroblast specialization has clear implications for the development of effective induction and maintenance therapies for patients with these clinically distinct diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Inflammation & Immunology Research Unit, Pfizer, Inc., Cambridge, Massachusetts, 02139, USA.
ORCID-Profile: Alexander M S Barron
Förderung
- Pfizer
Zitieren
APA
M S Barron, A., Fabre, T., & De, S. (2024). Distinct fibroblast functions associated with fibrotic and immune-mediated inflammatory diseases and their implications for therapeutic development. F1000Research, 13, 54. https://doi.org/10.12688/f1000research.143472.1
Vancouver
M S Barron A, Fabre T, De S. Distinct fibroblast functions associated with fibrotic and immune-mediated inflammatory diseases and their implications for therapeutic development. F1000Research. 2024;13:54. doi:10.12688/f1000research.143472.1
BibTeX
@article{MSBarron2024,
author = {M S Barron, Alexander and Fabre, Thomas and De, Saurav},
title = {Distinct fibroblast functions associated with fibrotic and immune-mediated inflammatory diseases and their implications for therapeutic development},
journal = {F1000Research},
year = {2024},
volume = {13},
pages = {54},
doi = {10.12688/f1000research.143472.1}
}
EUVIMED